Sign in

Filings

Finds words inside filing documents. Searching ArriVent BioPharma, Inc.'s filings · 43 documents indexed.

2 documents · 14 matches

  1. AVBP ArriVent BioPharma, Inc. DRS/A 2023-10-04

    material weakness we identified or develop or to maintain internal control over financial reporting could severely inhibit our ability to accurately
    11 matches in this document
  2. AVBP ArriVent BioPharma, Inc. 10-K 2026-03-05

    Item 1A. Risk Factors

    material weakness or uncover other errors in financial reporting. During the course of our evaluation of these material weaknesses, we may identify
    3 matches in this document

Page 1 of 1 · 2 documents